Research & KnowledgeEvent: September 7, 2026
Applied research using Omic Sciences announced that SELLAS Life Sciences Group, Inc. and the University of Wisconsin will present three studies at the AACR Conference on Pancreatic Cancer examining the relationship between MYC allelic imbalance and therapeutic response in patient-derived PDAC organoids, combined BET and CDK9 inhibition in MYC-amplified PDAC, and combined KRAS G12D and CDK9 inhibition.
Published
Signal category
Research & Knowledge
Quote
“SELLAS Life Sciences Group, Inc. and the University of Wisconsin will present three studies at the AACR Conference on Pancreatic Cancer examining”
— Carme Plasencia|Applied research using Omic Sciences team
Company
Applied research using Omic Sciences
Development of novel therapeutic and diagnostic products
- Industry
- Biotechnology Research
- Location
- Barcelona, ES
- Company size
- 1 employees